Antituberculosis drug resistance and anonymous HIV surveillance in tuberculosis patients in Botswana, 2002.
about
Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South AfricaLow specificity of HIV-testing on sputum specimens kept at ambient temperatures for 4 to 7 days: a blinded comparisonEpidemiology and treatment of multidrug resistant tuberculosisRate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, UgandaGlobal control of tuberculosis: from extensively drug-resistant to untreatable tuberculosisRD antigen based nanovaccine imparts long term protection by inducing memory response against experimental murine tuberculosis.Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana.Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.HIV infection and multidrug-resistant tuberculosis: the perfect storm.Underreported threat of multidrug-resistant tuberculosis in Africa.Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.Safety and efficacy of nevirapine- and efavirenz-based antiretroviral treatment in adults treated for TB-HIV co-infection in BotswanaEarly immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosisIncrease in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance SurveyTrends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.Improved survival and cure rates with concurrent treatment for MDR-TB/HIV co-infection in South Africa.
P2860
Q21562122-A1E5AD5C-A663-411F-8202-68DD59602FACQ33299619-8F0D25B1-4F45-4711-87AE-B2DDA857CDF4Q33710690-405C8DEB-CB53-4939-AE3B-DF08ECB5CDA7Q33904830-D165FE5A-4068-4E43-9993-37D5706D31CAQ33926262-AC242179-3A4D-4650-85C9-68536EE3BC37Q33996844-542E9503-61E5-42FB-BE5A-D85B2F905574Q35173497-5FA724D1-05C3-4269-857F-372E72BDFC5BQ35370503-E8936DEA-AAB4-4DDE-B7AE-36DEA4982764Q35546001-92F8D874-87DB-4998-804F-178839CE6993Q36877246-DE1BAFAC-7D96-4624-AC6C-A5AFC5950A64Q37015566-EB6654E4-4A62-4E87-ADC0-F4FE0E486FA9Q37145913-D41F7FEE-B732-47EF-B9B9-60E0B539A222Q37227388-94A2798A-5851-46E8-AA6E-C98F61B09606Q37272336-D3355ACB-07A6-4B91-B832-0F1A77262EC5Q40794905-76FEE2F6-2757-4B0D-848F-3A6399081288Q41930740-9A172AE0-B508-4C7A-95CC-64D04A8DF5CFQ47558685-277AFD0E-89F5-46CC-BC4E-B9F43D8B8A47
P2860
Antituberculosis drug resistance and anonymous HIV surveillance in tuberculosis patients in Botswana, 2002.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Antituberculosis drug resistan ...... is patients in Botswana, 2002.
@en
type
label
Antituberculosis drug resistan ...... is patients in Botswana, 2002.
@en
prefLabel
Antituberculosis drug resistan ...... is patients in Botswana, 2002.
@en
P2093
P921
P1433
P1476
Antituberculosis drug resistan ...... is patients in Botswana, 2002.
@en
P2093
E A Talbot
L J Nelson
M J Mwasekaga
P K Ngirubiu
R A Mwansa
P304
P356
10.1016/S0140-6736(05)67062-6
P407
P577
2005-08-01T00:00:00Z